IGM Biosciences

IGMS50

$17.23arrow_drop_up3.48%$0.58

IGMS50

$17.23

arrow_drop_up3.48%$0.58

Performance History

Key Stats
Open	$17.30
Prev. Close	$16.65
EPS	-3.57
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	16.42	18.69
52 Week Range	3.81	22.50

Ratios







EPS	-3.57

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About IGM Biosciences (IGMS)

IGM Biosciences Inc. (IGMS) is a biotechnology company that focuses on the discovery and development of engineered immunoglobulin M (IgM) antibodies for the treatment of cancer. The company's proprietary technology platform allows for the generation of IgM antibodies that have enhanced functional properties and improved therapeutic potential compared to traditional IgG antibodies. By harnessing the unique properties of IgM antibodies, IGM Biosciences aims to develop novel therapies that can address unmet needs in the field of oncology.

IGM Biosciences was founded in 2010 and is headquartered in Mountain View, California. The company's lead product candidate is IGM-2323, which is being developed for the treatment of relapsed/refractory (R/R) B-cell malignancies. Preclinical studies have demonstrated that IGM-2323 has the potential to selectively bind and eliminate tumor cells, while sparing normal cells. The company is also developing a pipeline of other IgM antibodies, targeting different cancer types and pathways.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Fred M. Schwarzer J.D.
Headquarters: Mountain View
Employees: 289
Exchange: NASDAQ

Keep an eye on IGM Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is IGM Biosciences 's (IGMS) price per share?

The current price per share for IGM Biosciences (IGMS) is $17.23. The stock has seen a price change of $0.58 recently, indicating a 3.48% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for IGM Biosciences (IGMS)?

For IGM Biosciences (IGMS), the 52-week high is $22.5, which is 30.59% from the current price. The 52-week low is $3.81, the current price is 352.23% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is IGM Biosciences (IGMS) a growth stock?

IGM Biosciences (IGMS) has shown an average price growth of 0.41% over the past three years. It has received a score of 8 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying IGM Biosciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is IGM Biosciences (IGMS) stock price performance year to date (YTD)?

As of the latest data, IGM Biosciences (IGMS) has a year-to-date price change of 98.5%. Over the past month, the stock has experienced a price change of 79.67%. Over the last three months, the change has been 137.98%. Over the past six months, the figure is 65.04%. Looking at a longer horizon, the five-year price change stands at -29.09%.

help

Is IGM Biosciences (IGMS) a profitable company?

IGM Biosciences (IGMS) has a net income of -$246.42M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -4.1K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $2.13M, with a revenue growth rate of 99.25%, providing insight into the company's sales performance and growth. Operating income is noted at -$263.46M. Furthermore, the EBITDA is -$226.37M.

help

What is the market capitalization of IGM Biosciences (IGMS)?

IGM Biosciences (IGMS) has a market capitalization of $1.05B. The average daily trading volume is 458.72K, indicating the stock's liquidity and investor engagement.

News

Russell 2000 Outpaces S&P 500 As Small Caps Anticipate Fed's Interest Rate Move

Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is 'Clouded By Fed's Concerns Over Labor Market,' Analyst Warns - Benzinga

CALENDAR OF EVENTS

HEALTH

5/29/2024

IGM Biosciences to Present at the Jefferies Healthcare Conference